Re: [新聞] 增3死、中重症+21 「女嬰發燒送加護

※ 引述《zangetsu9006 (台灣是平行時空)》之銘言：
: 所以我說那個口服藥呢？
: https://i.imgur.com/l1gJJBe.jpg

說來聽聽吧

我準備好資料要來打你臉了

: 這種條件還敢跟國外一樣搞共存
: 我也只能呵呵…
: 當年我兒子燒個不停，醫生只是懷疑得流感，就立刻開克流感
: 怎麼現在確診Covid-19 ，就只是待在家裡，吃清冠一號！？
: 超前部署？
: 去年爆發沒疫苗，拖到果凍看不下去，跟台積電、慈濟聯合掏腰包買BNT，外國還捐了一
: 堆AZ給我們，美國爸爸也捐了莫德納
: 今年爆發沒口服藥、快篩，是不是又要拖到民間看不下去、拖到美國爸爸、日本哥哥看不
: 下去！？
: 台灣的臉都被丟光了！還敢講「看好了世界，台灣只示範一次」、「Taiwan can help」
: 自求多福吧…各位台灣同胞…
: 自己選的，自己承擔
: 四個不同意，共存更給力

依照用藥說明書載明，該藥與多種心臟血管用藥、止痛藥、抗癌藥、抗凝血藥、抗痙攣藥、抗憂鬱或精神病劑、抗痛風藥、HIV與C型肝炎等抗病毒劑、抗感染劑、荷爾蒙避孕藥、免疫抑制劑、麻醉、鎮靜或安眠藥，以及全身性類固醇等藥品會產生交互作用。

一確診就無腦給Paxlovid

然後遇到上面說的對象

責任算誰的？

說看看啊

--

笑死 這根本不是政府的文章

5. Can anyone get a Paxlovid prescription? The FDA authorized Paxlovid for people ages 12 and older who weigh at least 88 pounds. But in order to qualify for a prescription, you must also have had a positive COVID-19 test result and be at high risk for developing severe COVID- 19. That means you must either have certain underlying conditions (including cance r, diabetes, obesity, or others) or be 65 or older (more than 81% of COVID-19 deaths occur in in this group). The more underlying medical conditions a perso n has, the higher their risk for developing a severe case of COVID-19, accordi ng to the CDC. 並不是你說的篩陽就給藥喔 英文不太好？

英國這做法合理，但仍然不夠安全

Before prescribing ritonavir-boosted nirmatrelvir, clinicians should carefully review the patient’s concomitant medications, including over-the-counter med ications, herbal supplements, and recreational drugs, to evaluate potential dr ug-drug interactions. 看來你英文真的不好

所以有篩陽就給藥嗎？

CONTRAINDICATIONS History of clinically significant hypersensitivity reactions to the active ing redients (nirmatrelvir or ritonavir) or any other components. (4) ‧ Co-admini stration with drugs highly dependent on CYP3A for clearance and for which elev ated concentrations are associated with serious and/or life-threatening reacti ons. (4, 7.3) ‧ Co-administration with potent CYP3A inducers where significan tly reduced nirmatrelvir or ritonavir plasma concentrations may be associated with the potential for loss of virologic response and possible resistance. WARNINGS AND PRECAUTIONS The concomitant use of PAXLOVID and certain other drugs may result in potentia lly significant drug interactions. Consult the full prescribing information pr ior to and during treatment for potential drug interactions. (5.1, 7) ‧ Aller gic Reactions/Hypersensitivity: Hypersensitivity reactions have been reported with PAXLOVID. If signs and symptoms of a clinically significant hypersensitiv ity reaction or anaphylaxis occur, immediately discontinue PAXLOVID and initia te appropriate medications and/or supportive care. (5.2) ‧ Hepatotoxicity: He patic transaminase elevations, clinical hepatitis, and jaundice have occurred in patients receiving ritonavir. (5.3) ‧ HIV-1 Drug Resistance: PAXLOVID use may lead to a risk of HIV-1 developing resistance to HIV protease inhibitors i n individuals with uncontrolled or undiagnosed HIV-1 infection. (5.4) 打臉打到手有點酸

看來你真的看不懂英文XD

根本沒有篩陽就給藥這事情 都要先審視用藥者的狀況